Accelerating Progress in Oncogene-driven Lung Cancer
from Conversations in Lung Cancer Research Hosted by Deme Karikios, Wanda Cui, Chris Karapetis
Deme Karikios, Medical Oncologist and Director of Clinical trials at Nepean Cancer Care Centre in Sydney is joined by Wanda Cui, Medical Oncologist from the Peter MacCallum Cancer Centre in Melbourne and Chris Karapetis, Head of the Department of Medical Oncology and Director of Clinical Research at the Flinders Medical Centre in Adelaide. --------------- Support TOGA Thank you for listening to Conversations in Lung Cancer Research. If you enjoyed this episode, please rate and review us on Apple Podcasts or Spotify. --------------- Connect with TOGA Attend an Event: https://thoraciconcology.org.au/events/ Become a Member: Join the TOGA community at https://thoraciconcology.org.au/membership/ Donate: Support our research and treatment initiatives at https://thoraciconcology.org.au/support-us/donate/ Follow Us LinkedIn: https://www.linkedin.com/company/thoracic-oncology-group-of-australasia/ X (Twitter): https://x.com/TOGAANZ Instagram: https://www.instagram.com/togaanz/ YouTube: https://www.youtube.com/@Thoracic_Oncology --------------- Acknowledgement of Country The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.
Embed this episode
What this episode covers
Join us for the latest TOGA podcast about Accelerating Progress in Oncogene-driven Lung Cancer, Deme , Wanda and Chris discuss the advances in oncogene-driven lung cancer and what this means for trial design, patients and treatment practices in Australia. We examine the survival data for the common and not so common mutated lung cancers, as well as the future view.
No transcript yet.